Braskem (BAK) Notes Payables (2009 - 2025)

Braskem (BAK) has reported Notes Payables for 17 consecutive years, with $1.5 billion the latest figure, recorded in Q4 2025.

• Quarterly Notes Payables rose 291.24% year-over-year to $1.5 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.5 billion (up 291.24% YoY) and the FY2025 annual result came in at $1.5 billion, up 291.24% from the prior year.
• Notes Payables fell to $1.5 billion in Q4 2025 per BAK's latest filing, from $8.1 billion in the prior quarter.
• Over the last five years, Notes Payables for BAK reached as high as $8.1 billion in Q1 2025 and fell as low as $173.1 million in Q3 2021.
• A 5-year average of $1.6 billion and a median of $392.0 million in 2024 frame the typical range for Notes Payables.
• Annual changes were most pronounced in 2024 — Notes Payables fell 4.36% — and 2025, when it jumped 291.24%.
• Year by year, Notes Payables stood at $240.9 million in 2021, then advanced by 9.07% to $262.7 million in 2022, then surged by 56.01% to $409.9 million in 2023, then slipped by 4.36% to $392.0 million in 2024, then soared by 291.24% to $1.5 billion in 2025.
• According to Business Quant data, Notes Payables over the past three periods registered $1.5 billion, $8.1 billion, and $392.0 million for Q4 2025, Q1 2025, and Q4 2024 respectively.